Novartis AG (NVS)
104.28
+0.43
(+0.41%)
USD |
NYSE |
Nov 22, 16:00
104.00
-0.28
(-0.27%)
Pre-Market: 05:05
Novartis Gross Profit Margin (Quarterly): 75.45% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 75.45% |
| June 30, 2024 | 75.35% |
| March 31, 2024 | 74.46% |
| December 31, 2023 | 74.34% |
| September 30, 2023 | 74.22% |
| June 30, 2023 | 71.55% |
| March 31, 2023 | 72.92% |
| December 31, 2022 | 72.27% |
| September 30, 2022 | 73.35% |
| June 30, 2022 | 71.33% |
| March 31, 2022 | 69.91% |
| December 31, 2021 | |
| September 30, 2021 | 70.54% |
| June 30, 2021 | 70.56% |
| March 31, 2021 | 68.18% |
| December 31, 2020 | 67.64% |
| September 30, 2020 | 70.07% |
| June 30, 2020 | 70.50% |
| March 31, 2020 | 70.71% |
| December 31, 2019 | 68.61% |
| September 30, 2019 | 69.75% |
| June 30, 2019 | 71.67% |
| March 31, 2019 | 71.62% |
| December 31, 2018 | 66.06% |
| September 30, 2018 | 69.59% |
| Date | Value |
|---|---|
| June 30, 2018 | 69.47% |
| March 31, 2018 | 69.09% |
| December 31, 2017 | 85.28% |
| September 30, 2017 | 65.94% |
| June 30, 2017 | 65.92% |
| March 31, 2017 | 65.17% |
| December 31, 2016 | 64.39% |
| September 30, 2016 | 64.61% |
| June 30, 2016 | 64.89% |
| March 31, 2016 | 64.34% |
| December 31, 2015 | 64.47% |
| September 30, 2015 | 64.85% |
| June 30, 2015 | 65.21% |
| March 31, 2015 | 67.38% |
| December 31, 2014 | 66.93% |
| September 30, 2014 | 66.76% |
| June 30, 2014 | 68.61% |
| March 31, 2014 | 68.31% |
| December 31, 2013 | 67.51% |
| September 30, 2013 | 68.03% |
| June 30, 2013 | 69.22% |
| March 31, 2013 | 67.58% |
| December 31, 2012 | 76.82% |
| September 30, 2012 | 67.41% |
| June 30, 2012 | 68.30% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.64%
Minimum
Dec 2020
75.45%
Maximum
Sep 2024
71.68%
Average
71.33%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 77.29% |
| Eli Lilly and Co | 81.02% |
| Novo Nordisk AS | 84.14% |
| Pfizer Inc | 70.27% |
| Monte Rosa Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.89% |
| Return on Assets | 17.33% |
| Return on Invested Capital | 25.80% |
| Profit Margin (Quarterly) | 24.21% |
| Operating Margin (Quarterly) | 27.54% |
| Return on Net Operating Assets | 22.97% |